<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03682445</url>
  </required_header>
  <id_info>
    <org_study_id>GFindikoglu</org_study_id>
    <nct_id>NCT03682445</nct_id>
  </id_info>
  <brief_title>Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus</brief_title>
  <official_title>Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamukkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamukkale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effects of high intensity interval exercise and
      moderate intensity continuous exercise on metabolic parameters, physical measures, fitness
      level, body composition and miRNA-143 level in patients with type 2 diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication
      that will restrain them from making exercise. 90 male or female volunteers who are suitable
      in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be
      randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1.
      group will make aerobic exercise which is in the form of high intensity interval exercise
      2.group will make aerobic exercise which is in the form of moderate intensity continuous
      exercise 3. Control group. Exercise groups will be cycling under observation in the hospital
      setting. Control group will make simple stretching exercises at home. Participants will be
      requested to complete a 3 months of exercise. They will be evaluated before and at the end of
      the 3 months of exercise with physical measures such as waist and hip circumference, fitness
      level measured by exercise testing, body composition measured by bioimpedance, metabolic
      parameters such as blood glucose level, HbA1C and measured by blood tests.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study has 3 arms.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants wil be making exercise. It is not possible to make participants blinded to the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c level.</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in HbA1c level measured in the blood after exercise compared to beginning</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Type2 Diabetes Mellitus</condition>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>High intensity interval exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants with type 2 Diabetes mellitus in High intensity interval exercise (HIIE) group will make aerobic exercise using bicycle at high intensity followed by low intensity periods under observation in the hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate intensity continuous exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants with type 2 Diabetes mellitus in Moderate intensity continuous exercise (MIC) group will make aerobic exercise using bicycle at moderate intensity during the session under observation in the hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The participants in the control group will make stretching exercise at home</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>Aerobic tyep of exercise will be made at different intensities in 2 groups.</description>
    <arm_group_label>High intensity interval exercise</arm_group_label>
    <arm_group_label>Moderate intensity continuous exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participants must have type 2 Diabetes mellitus less than 10 years and more than 1
             year.

          2. Participants must have appropriate medical therapy and diet.

          3. Participants must not be treated with insulin.

          4. Participants must be exercising less than 210 minutes/ week.

        Exclusion Criteria:

          1. Participants with prominent cardiovascular disease

          2. Participants with coronary artery disease

          3. Participants with moderate to severe valvular disease

          4. Participants with atrial fibrillation

          5. Participants with untreated hypertension

          6. Participants with congenital heart disease

          7. Participants with retinopathy

          8. Participants with neuropathy

          9. Participants with macro albuminuria

         10. Participants with cerebrovascular disease

         11. Participants with ejection fraction less than 40

         12. Participants with body mass index greater than 35.

         13. Participants with prominent ischemic changes in EKG at rest or during exercise.

         14. Participants with cigarette or alcohol addiction

         15. Participants on drugs that interferes with body fat distribution (such as insulin,
             thiazolidinediones)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gulin Findikoglu, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>pamukkale university, Medical Faculty, PMR Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gulin Findikoglu, MD PhD</last_name>
    <phone>90 258 2966000</phone>
    <phone_ext>4956</phone_ext>
    <email>gulin_dr@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abdurrahim Altınkapak, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>20100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GÜLİN FINDIKOGLU</last_name>
      <phone>05334227076</phone>
      <email>gulin_dr@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>21600</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulin Findikoglu, MD, PhD</last_name>
      <phone>90 258 2966000</phone>
      <phone_ext>4956</phone_ext>
      <email>gulin_dr@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Abdurrahim Altınkapak, MD</last_name>
      <phone>90 258 2966000</phone>
      <phone_ext>6781</phone_ext>
      <email>abdurrahim_alt@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2018</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pamukkale University</investigator_affiliation>
    <investigator_full_name>GULIN FINDIKOGLU</investigator_full_name>
    <investigator_title>Associate Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes mellitus</keyword>
  <keyword>exercise</keyword>
  <keyword>aerobic</keyword>
  <keyword>interval</keyword>
  <keyword>continuous</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

